Med BioGene diagnostic news
Diagnostic company Med BioGene said that four shareholders filed a petition in the British Columbia Supreme Court. The petition makes claims against the company relating to the adoption of the Advance Notice Policy by the board in advance of the May 17 annual general meeting; Med BioGene's subsequent rejection of a notice of intention from Iain Weir-Jones - one of the petitioners - to nominate himself and another person as directors of the company; and decisions made at the meeting by the chairman. Med BioGene said the dissident shareholders are seeking from the court an order convening a new annual general meeting of the company and allowing the shareholders to nominate individuals for election as directors. The biotech said it adopted the Advance Notice Policy "as a matter of good corporate governance" and that it provides "a clear framework" for nominating directors. The company could not be reached for details. ...